Literature DB >> 23801420

The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis: a meta-analysis.

Julia Nierhoff1, Andrea Angelina Chávez Ortiz, Eva Herrmann, Stefan Zeuzem, Mireen Friedrich-Rust.   

Abstract

OBJECTIVES: Acoustic radiation force impulse (ARFI) imaging is an ultrasound-based elastography method that is integrated into a conventional ultrasound machine. A meta-analysis based on original and abstract publications was performed to evaluate the overall performance of ARFI for the diagnosis of liver fibrosis.
METHODS: Literature databases and conference abstracts were searched from 2007 up to February 2012. A random effects meta-analysis of the area under the receiver operating characteristic (ROC) curve (AUROC) and the diagnostic odds ratio (DOR) was performed as well as summary ROC curve techniques. Quality analyses were conducted to assess sources of heterogeneity.
RESULTS: The systematic literature search revealed 36 studies, with 3,951 patients overall. The mean diagnostic accuracy of ARFI expressed as the AUROC was 0.84 (DOR, 11.54) for the diagnosis of significant fibrosis (F ≥ 2), 0.89 (DOR, 33.54) for the diagnosis of severe fibrosis (F ≥ 3) and 0.91 (DOR, 45.35) for the diagnosis of liver cirrhosis (F = 4). Subgroup analyses showed sources of heterogeneity between the different underlying liver diseases for F ≥ 3 and F = 4. The mean body mass index had a significant influence for F ≥ 2.
CONCLUSIONS: The meta-analysis revealed good diagnostic accuracy of the ARFI imaging for the staging of F ≥ 2 and F ≥ 3, and excellent diagnostic accuracy for F = 4. KEY POINTS: • Acoustic radiation force impulse (ARFI) imaging adds important information over conventional ultrasound. • ARFI imaging provides good diagnostic performance for assessing significant/severe hepatic fibrosis. • ARFI imaging shows excellent diagnostic accuracy and odds ratio for cirrhosis staging. • Body mass index significantly influences the assessment of significant fibrosis.

Entities:  

Mesh:

Year:  2013        PMID: 23801420     DOI: 10.1007/s00330-013-2927-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  50 in total

1.  Diagnosis, management, and treatment of hepatitis C.

Authors:  Doris B Strader; Teresa Wright; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography.

Authors:  F Piscaglia; V Salvatore; R Di Donato; M D'Onofrio; S Gualandi; A Gallotti; E Peri; A Borghi; F Conti; G Fattovich; E Sagrini; A Cucchetti; P Andreone; L Bolondi
Journal:  Ultraschall Med       Date:  2011-02-14       Impact factor: 6.548

4.  Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.

Authors:  Masato Yoneda; Kaori Suzuki; Shingo Kato; Koji Fujita; Yuichi Nozaki; Kunihiro Hosono; Satoru Saito; Atsushi Nakajima
Journal:  Radiology       Date:  2010-06-07       Impact factor: 11.105

5.  Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease.

Authors:  Mark L Palmeri; Michael H Wang; Ned C Rouze; Manal F Abdelmalek; Cynthia D Guy; Barry Moser; Anna Mae Diehl; Kathryn R Nightingale
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

6.  Noninvasive assessment of liver fibrosis with acoustic radiation force impulse imaging: increased liver and splenic stiffness in patients with liver fibrosis and cirrhosis.

Authors:  I Grgurevic; I Cikara; J Horvat; I K Lukic; R Heinzl; M Banic; M Kujundzic; B Brkljacic
Journal:  Ultraschall Med       Date:  2010-11-23       Impact factor: 6.548

7.  Acoustic radiation force imaging sonoelastography for noninvasive staging of liver fibrosis.

Authors:  Carmen Fierbinteanu-Braticevici; Dan Andronescu; Radu Usvat; Dragos Cretoiu; Cristian Baicus; Gabriela Marinoschi
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography.

Authors:  Mireen Friedrich-Rust; Katrin Wunder; Susanne Kriener; Fariba Sotoudeh; Swantje Richter; Joerg Bojunga; Eva Herrmann; Thierry Poynard; Christoph F Dietrich; Johannes Vermehren; Stefan Zeuzem; Christoph Sarrazin
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

9.  A meta-analysis of transient elastography for the detection of hepatic fibrosis.

Authors:  Justin Stebbing; Lavanta Farouk; George Panos; Mike Anderson; Long R Jiao; Sundhiya Mandalia; Mark Bower; Brian Gazzard; Mark Nelson
Journal:  J Clin Gastroenterol       Date:  2010-03       Impact factor: 3.062

10.  The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis.

Authors:  Jong Ho Chung; Hyung Su Ahn; Sang Gyune Kim; Yun Nah Lee; Young Seok Kim; Soung Won Jeong; Jae Young Jang; Sae Hwan Lee; Hong Soo Kim; Boo Sung Kim
Journal:  Clin Mol Hepatol       Date:  2013-06-27
View more
  53 in total

Review 1.  Critical comparison of elastography methods to assess chronic liver disease.

Authors:  Mireen Friedrich-Rust; Thierry Poynard; Laurent Castera
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-06-08       Impact factor: 46.802

2.  Diagnostic accuracy of two-dimensional shear wave elastography for the non-invasive staging of hepatic fibrosis in chronic hepatitis B: a cohort study with internal validation.

Authors:  Jie Zeng; Guang-Jian Liu; Ze-Ping Huang; Jian Zheng; Tao Wu; Rong-Qin Zheng; Ming-De Lu
Journal:  Eur Radiol       Date:  2014-07-17       Impact factor: 5.315

3.  MR elastography of the liver at 3.0 T in diagnosing liver fibrosis grades; preliminary clinical experience.

Authors:  Kengo Yoshimitsu; Toshimichi Mitsufuji; Yoshinobu Shinagawa; Ritsuko Fujimitsu; Ayako Morita; Hiroshi Urakawa; Hiroyuki Hayashi; Koichi Takano
Journal:  Eur Radiol       Date:  2015-06-10       Impact factor: 5.315

4.  Non invasive tools for the diagnosis of liver cirrhosis.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Melchiorre Cervello; Anna Licata; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

5.  Cost-utility analysis of nonalcoholic steatohepatitis screening.

Authors:  Eric Zhang; Claire Wartelle-Bladou; Luigi Lepanto; Jean Lachaine; Guy Cloutier; An Tang
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

6.  Assessment of liver fibrosis in chronic hepatitis B using acoustic structure quantification: quantitative morphological ultrasound.

Authors:  Yang Huang; Zhu Wang; Bing Liao; Jin-Yu Liang; Lu-Yao Zhou; Fen Wang; Wei Li; Jin-Ya Liu; Xiao-Yan Xie; Ming-De Lu; Guang-Jian Liu; Wei Wang
Journal:  Eur Radiol       Date:  2015-10-20       Impact factor: 5.315

Review 7.  Non-invasive diagnosis of advanced fibrosis and cirrhosis.

Authors:  Suraj Sharma; Korosh Khalili; Geoffrey Christopher Nguyen
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 8.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 9.  Noninvasive diagnosis of cirrhosis: a review of different imaging modalities.

Authors:  Riccardo De Robertis; Mirko D'Onofrio; Emanuele Demozzi; Stefano Crosara; Stefano Canestrini; Roberto Pozzi Mucelli
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

10.  Preliminary Results on the Feasibility of Using ARFI/SWEI to Assess Cutaneous Sclerotic Diseases.

Authors:  Seung Yun Lee; Adela R Cardones; Joshua Doherty; Kathryn Nightingale; Mark Palmeri
Journal:  Ultrasound Med Biol       Date:  2015-08-08       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.